The TrkB receptor is critical for the control of energy balance, as mutations in its gene (NTRK2) lead to hyperphagia and severe obesity in humans and mice. The main neural substrate mediating the appetite-suppressing activity of TrkB, however, remains unknown. Here, we demonstrate that selective Ntrk2 deletion within the paraventricular hypothalamus (PVH) leads to severe hyperphagic obesity. Furthermore, chemogenetic activation or inhibition of TrkB-expressing PVH (PVH TrkB ) neurons suppresses or increases food intake, respectively. PVH TrkB neurons project to multiple brain regions, including the ventromedial hypothalamus (VMH) and the lateral parabrachial nucleus (LPBN). We found that PVH TrkB neurons projecting to LPBN are distinct from those projecting to VMH, yet Ntrk2 deletion in PVH neurons projecting to either VMH or LPBN results in hyperphagia and obesity. Therefore, TrkB signaling is a key regulator of a previously uncharacterized and heterogenous neuronal population within the PVH that impinges upon multiple circuits to govern appetite.
INTRODUCTION
The regulation of food intake is essential for survival in all organisms, and its dysregulation not only affects survival but also causes health problems such as obesity. Several ligand-receptor pairs play a crucial role in the central regulation of energy balance. They include leptin and the leptin receptor, alpha-melanocyte-stimulating hormone (aMSH) and the melanocortin-4 receptor (MC4R), and brain-derived neurotrophic factor (BDNF) and the TrkB receptor. Defects in any of these three ligand-receptor pairs lead to severe obesity in humans [1] [2] [3] [4] [5] and mice [6] [7] [8] [9] [10] [11] . Furthermore, several common single nucleotide polymorphisms in the MC4R and BDNF genes have been found to be associated with increased body mass index in large-scale genome-wide association studies [12] [13] [14] [15] . Remarkable progress has been made in elucidation of neural circuits that mediate the effects of leptin and aMSH on energy balance 16 . By comparison, much less is known about the neural substrate through which the BDNF-TrkB pathway regulates appetite and energy expenditure.
BDNF is well known for its role in neuronal development and synaptic function [17] [18] [19] . It signals through the binding of two distinct classes of receptor proteins: the tropomyosin receptor kinase B (TrkB) and the p75 neurotrophin receptor (p75 NTR ). Mutations in the NTRK2 gene, which codes for TrkB, lead to severe obesity in mice and humans 4, 11 . Conversely, no obesity phenotype has been observed in mice lacking the p75 NTR receptor 20 . In fact, mice lacking the p75 NTR receptor are protected from obesity induced by high-fat diet and remain lean due to increased energy expenditure 21 . Therefore, BDNF should signal through TrkB to regulate energy balance. The paraventricular hypothalamus (PVH) and the ventromedial hypothalamus (VMH) have been identified as two important brain areas that express BDNF to suppress food intake and promote energy expenditure [22] [23] [24] . However, it remains unclear in which population of hypothalamic neurons TrkB is required for the control of energy balance and how these TrkB-expressing neurons regulate food intake and/or energy expenditure. Our recent work found that Ntrk2 deletion in the dorsomedial hypothalamus (DMH) led to modest hyperphagia and obesity 26 , but to a much lesser extent in comparison with Ntrk2 hypomorphic mice in which Ntrk2 expression is reduced to a quarter of the normal amount throughout the body 11 , indicating that the main neural substrate underlying the action of TrkB signaling on energy balance remains to be identified.
Here we report that TrkB-expressing PVH (PVH TrkB ) neurons are distinct from neurons that express BDNF, MC4R, or prodynorphin (PDYN) in the PVH, the three subtypes of neurons that are known to suppress appetite 22, 27, 28 . We found that chemogenetic inhibition of PVH TrkB neurons greatly increased food intake, whereas chemogenetic activation of these neurons drastically reduced food intake. Furthermore, we found that deletion of the Ntrk2 gene in the PVH led to severe hyperphagic obesity. We then designed a projection-specific gene deletion approach and used this approach to reveal that PVH TrkB neurons project to the VMH and the lateral parabrachial nucleus (LPBN) to suppress food intake. These studies not only identify the main neural substrate by which TrkB signaling regulates energy balance, but also implicates the PVH ® VMH neurocircuit in the control of appetite.
RESULTS

Many TrkB neurons in the PVH are distinct from previously defined ones
The PVH is a heterogeneous brain structure with many different cell types 29, 30 . At least 10 types of PVH neurons can be molecularly defined by the expression of BDNF, corticotropin-releasing hormone (CRH), growth hormone-releasing hormone (GHRH), MC4R, oxytocin, prodynorphin (PDYN), somatostatin, tyrosine hydroxylase, thyrotropin-releasing hormone (TRH), and vasopressin 22, 27, 28, 31 . We previously found that approximately 5% PVH TrkB neurons expressed BDNF 22 . We sought to determine whether PVH TrkB neurons belong to other defined neuronal populations.
TrkB antibodies do not mark cell bodies well in brain sections, because TrkB is distributed to the membrane of both cell bodies and processes. We employed the Ntrk2 CreER/+ mouse strain 32 , in which the Cre-ERT2 sequence is inserted into the Ntrk2 locus immediately after the first coding ATG, for colocalization studies. We crossed Ntrk2 CreER/+ mice to Rosa26 Ai9/+ mice 33 to generate Ntrk2 CreER/+ ;Rosa26 Ai9/+ mice, in which TrkB-expressing cells express tdTomato after tamoxifen treatment. Since the kinase-lacking truncated TrkB is expressed in astrocytes 34 , tdTomato should also label astrocytes. We detected many tdTomato-labelled TrkB cells in the PVH (Fig. 1a ), which are either neurons that are positive for the neuronal marker NeuN ( Supplementary Fig. 1a ) or astrocytes that are positive for glial fibrillary acidic protein ( Supplementary Fig. 1b ). We noticed that there was a high colocalization between TrkB and oxytocin in the PVH (18% TrkB neurons express oxytocin and 51% oxytocin neurons express TrkB; Fig. 1b ). In addition, a small number of PVH TrkB neurons express TRH (2% TrkB neurons express TRH and 12% TRH neurons express TrkB; Fig. 1c ), PDYN (6% TrkB neurons express PDYN and 17% PDYN neurons express TrkB; Fig. 1d ), somatostatin (2% TrkB neurons express somatostatin and 16% somatostatin neurons express TrkB; Supplementary Fig. 1c ) and GHRH (5% TrkB neurons express GHRH and 30% GHRH neurons express TrkB; Supplementary Fig. 1d ). Note that higher percentages of PVH TrkB neurons are positive for these markers in the shown images ( Fig. 1 and Supplementary Fig. 1 ), because the images were taken from the area where these markers are expressed. Very few PVH TrkB neurons express CRH (Fig. 1e ), tyrosine hydroxylase ( Supplementary Fig. 1e ), or vasopressin ( Supplementary Fig. 1f ). We also examined colocalization of TrkB with MC4R in the PVH using the BAC Mc4r-EGFP mouse strain 35 . We only detected low colocalization of TrkB with MC4R in the PVH of tamoxifen-treated Ntrk2 CreER/+ ;Rosa26 Ai9/+ ;Mc4r-EGFP mice (3% TrkB neurons express MC4R and 10% MC4R neurons express TrkB; Fig. 1f ). These results indicate that the majority of PVH TrkB neurons are distinct from previously defined neuronal populations.
Deletion of the Ntrk2 gene with Sim1-Cre leads to obesity
We previously reported that Ntrk2 deletion in several hypothalamic areas using the Rgs9-Cre led to obesity 25 ; however, the obesity phenotype was not as severe as what we observed in Ntrk2 hypomorphic mice that express TrkB at ~25% of the normal amount throughout the body 11, 25 .
Given that Rgs9-Cre only deletes Ntrk2 in a small number of PVH neurons 25 and that stereotaxic injection of recombinant BDNF into the PVH reduces food intake and increases energy expenditure 36, 37 , this observation raises the possibility that TrkB expressed in the PVH (PVH TrkB hereafter) plays an important role in the control of energy balance. We tested this possibility by deleting Ntrk2 in the PVH.
We tested whether Sim1-Cre 38 is suitable for abolishment of Ntrk2 gene expression in the PVH by crossing Sim1-Cre mice to Ntrk2 fBZ/+ mice to generate Sim1-Cre;Ntrk2 fBZ/+ mice, in which β-galactosidase is expressed in otherwise TrkB-expressing neurons once the floxed Ntrk2 fBZ allele is deleted by Cre recombinase as shown in our previous studies 39, 40 . We detected many cells expressing β-galactosidase in the PVH ( Fig. 2a ), suggesting that Sim1-Cre is effective in abolishing TrkB expression in the PVH. In addition to the PVH, Sim1-Cre can also abolish TrkB expression in some neurons of other brain regions including the cerebral cortex, hippocampus, amygdala, thalamus and DMH ( Supplementary Fig. 2a-f ).
We crossed Sim1-Cre mice to Ntrk2 lox/lox mice, which express a normal amount of TrkB in the absence of Cre 41 , to produce Ntrk2 lox/lox (control) and Sim1-Cre;Ntrk2 lox/lox (mutant) mice. In situ hybridization confirmed that Ntrk2 expression was abolished in the PVH of Sim1-Cre;Ntrk2 lox/lox mice (Fig. 2b ). Male and female Sim1-Cre;Ntrk2 lox/lox mice at 16 weeks of age were 45% and 49% heavier than sex-matched control mice, respectively ( Fig. 2c, d) . The Sim1-Cre;Ntrk2 lox/lox mice also had a longer body ( Fig. 2e ) and larger adipose tissues relative to control mice ( Supplementary Fig 2g, h) . These results indicate that Sim1-Cre;Ntrk2 lox/lox mice develop obesity.
We then determined if increased energy intake and/or reduced energy expenditure contribute to the obesity phenotype displayed by Sim1-Cre;Ntrk2 lox/lox mice. At 8 weeks of age, female Sim1-Cre;Ntrk2 lox/lox mice daily consumed 24% more food than control mice ( Fig. 2f ). We employed indirect calorimetry to estimate energy expenditure in mice at 6 weeks of age when control and Sim1-Cre;Ntrk2 lox/lox mice had comparable body weights (Fig 2c) . Control and Sim1-Cre;Ntrk2 lox/lox mice had comparable oxygen consumption (VO2) during the light period when mice are mostly at sleep ( Fig. 2g, h ), suggesting Sim1-Cre;Ntrk2 lox/lox mice have a relatively normal basal metabolic rate. During the dark period, VO2 and locomotor activity in Sim1-Cre;Ntrk2 lox/lox mice were reduced by 15% and 51%, respectively, compared with control mice ( Fig. 2g -i). These results indicate that TrkB signaling in Sim1-Cre cells promote physical activity and energy expenditure. Collectively, our results indicate that Sim1-Cre;Ntrk2 lox/lox mice develop obesity due to increased food intake and reduced energy expenditure.
Selective Ntrk2 deletion in the adult PVH led to hyperphagic obesity
Sim1-Cre is expressed in other brain regions in addition to the PVH 38 ( Supplementary Fig. 2a-f ), so the obesity phenotype in Sim1-Cre;Ntrk2 lox/lox mice might result from Ntrk2 deletion in non-PVH neurons or cells. To validate a role for PVH TrkB in the regulation of energy balance, we stereotaxically injected neuron-tropic AAV2, either AAV2-CMV-Cre-GFP or AAV2-CMV-GFP, into the PVH of 8-wk-old female Ntrk2 lox/lox mice ( Fig. 3a ). Injection of AAV2-CMV-Cre-GFP selectively abolished Ntrk2 expression in the PVH (Fig. 3a2 ). Mice injected with AAV2-CMV-Cre-GFP are divided into two groups based on the extent of AAV infection in the PVH: AAV2-CMV-Cre-GFP (missed) and AAV2-CMV-Cre-GFP (hit) (Supplementary Table 1 ). Mice in the AAV2-CMV-Cre-GFP (hit) group developed severe obesity quickly, compared to mice in the AAV2-CMV-GFP group and the AAV2-CMV-Cre-GFP (Missed) group (Fig. 3b, c) . The severity of obesity in AAV-Cre-injected mice had a good correlation with the extent of AAV infection in the PVH (Fig. 3d ), but not along needle tracks or in other hypothalamic areas (Supplementary Table 1 ). These results show that PVH TrkB is critical for the control of energy balance.
Mice in the AAV2-CMV-Cre-GFP (hit) group displayed marked hyperphagia just two weeks after AAV injection and remained hyperphagic 10 weeks after injection ( Fig. 3e ). These mice had energy expenditure and respiratory exchange ratio comparable to control mice ( Fig. 3f , h), whereas their ambulatory activity was trending lower 2 weeks after injection and was reduced 10 weeks after injection ( Fig. 3g ). These results indicate that PVH TrkB regulates energy balance mainly by suppressing appetite.
We noticed that the extent of AAV infection along a needle track is correlated with injection volume. We sought to further verify the role of PVH TrkB in the control of appetite by injecting female Ntrk2 lox/lox mice with a smaller volume of AAV into the PVH to minimize infection in needle tracks and other hypothalamic nuclei. We detected very few AAV-transduced neurons in brain areas other than the PVH (mostly detected in Bregma -0.7 to -0.94 mm) in this batch of mice ( Supplementary Fig. 3a1-a3 ). In the PVH, Ntrk2 gene deletion did not cause neuronal loss during the course of the experiment ( Supplementary Fig. 3a4-a6 ). Mice injected with AAV2-CMV-Cre-GFP displayed the same phenotypes as we observed in the first batch of mice, i.e. severe hyperphagic obesity, increased linear growth and reduced ambulatory activity ( Supplementary  Fig. 3b -g). Interestingly, even unilateral Ntrk2 gene deletion was sufficient to cause significant obesity ( Supplementary Fig. 3b ), indicating the extreme importance of PVH TrkB in the control of energy balance. Furthermore, Ntrk2 gene deletion in the PVH also led to obesity in male mice ( Supplementary Fig. 3h ). We did not detect any toxic effect on PVH neurons from AAV transduction, as bilateral injection of AAV2-CMV-Cre-GFP into the PVH of wild-type mice did not alter body weight ( Supplementary Fig. 3i ).
Oxytocin neurons in the PVH may play a central role in the control of appetite. Ablation of the oxytocin receptor-expressing neurons in the hindbrain leads to overeating 42 . Loss of oxytocin neurons is associated with both Prader-Willi syndrome and SIM1 mutations, each of which leads to insatiable appetite and severe obesity in humans [43] [44] [45] [46] . Because a large number of oxytocin neurons express TrkB in the PVH (Fig. 1b ), we investigated whether TrkB signaling suppresses appetite through these neurons by deleting the Ntrk2 gene in oxytocin neurons using the Oxt Cre mouse strain 47 ( Supplementary Fig. 4a ). Ntrk2 deletion in oxytocin neurons did not affect body weight in mice of either sex ( Supplementary Fig. 4b , c).
Collectively, these selective gene deletion experiments show that signaling through the TrkB receptor potently suppresses appetite through non-oxytocin-expressing PVH neurons. They also indicate that TrkB signaling in the PVH somewhat promotes locomotion without significantly altering energy expenditure.
PVH TrkB neurons bidirectionally regulate food intake
As BDNF potently potentiates neuronal growth and synaptic function 19 , Ntrk2 deletion would impair the function of PVH TrkB neurons. The observation that Ntrk2 deletion in the PVH leads to hyperphagic obesity would implicate PVH TrkB neurons in the acute regulation of food intake. We tested this hypothesis by manipulating the activity of PVH TrkB neurons using designer receptors exclusively activated by designer drugs (DREADDs) and their ligand clozapine N-oxide (CNO) 48, 49 . We expressed stimulatory DREADD hM3D(Gq), inhibitory DREADD hM4D(Gi), or control mCherry in PVH TrkB neurons by injecting Cre-dependent AAV2-hSyn-DIO-hM3D(Gq)-mCherry, AAV2-hSyn-DIO-hM4D(Gi)-mCherry, or AAV2-hSyn-DIO-mCherry into the PVH of Ntrk2 CreER/+ mice. We subsequently induced the expression of the injected AAV vectors in PVH TrkB neurons by treating the mice with tamoxifen ( Fig. 4a, b ).
Administration of CNO did not alter food intake of Ntrk2 CreER/+ mice expressing mCherry during either the light or dark cycle or after fasting ( Fig. 4c-f ), indicating that CNO does not have any detectable nonspecific effect on feeding. Administration of CNO greatly increased food intake of Ntrk2 CreER/+ mice expressing hM4D(Gi)-mCherry during the light cycle when mice do not normally eat much food, compared with vehicle administration (Fig. 4c ). This result indicates that PVH TrkB neurons are active to maintain physiological satiation during the light cycle. Interestingly, inhibition of PVH TrkB neurons also increased food intake during the dark cycle when mice are physiologically hungry and ingest the vast majority of their daily energy intake ( Fig. 4d ), suggesting that the anorexigenic PVH TrkB neurons are not fully silenced when mice are physiologically hungry. Conversely, CNO administration drastically reduced food intake of Ntrk2 CreER/+ mice expressing hM3D(Gq)-mCherry during the dark cycle or after overnight fasting, compared with vehicle administration (Fig. 4e, f ). This result indicates that activation of PVH TrkB neurons is sufficient to suppress appetite. Taken together, these chemogenetic experiments indicate that PVH TrkB neurons are partially silenced to allow for feeding when mice are hungry, while being active to maintain physiological satiation during the light cycle, and thus PVH TrkB neurons play a critical role in the regulation of appetite by promoting satiety.
PVH TrkB neurons project to multiple brain areas
We sought to identify the downstream sites through which PVH TrkB neurons regulate appetite. To map the projections of PVH TrkB neurons in the brain, we injected Cre-dependent AAV2-CAG-FLEX-tdTomato into the PVH of adult Ntrk2 CreER/+ mice (Fig. 5a1 ). After tamoxifen treatment, tdTomato nicely labeled PVH TrkB neurons across the rostral-caudal axis ( Fig. 5a2-4 ). PVH TrkB neurons project to four main brain sites: the VMH (Fig. 5a5 ), the median eminence (ME; Fig. 5a5 ), the lateral parabrachial nucleus (LPBN; Fig. 5a6 ), and the nucleus tractus solitaris (NTS; Fig.   5a8 ). Lesser projections were detected in the medial parabrachial nucleus (MPBN; Fig. 5a6 ), the locus coeruleus (LC; Fig. 5a7 ), the dorsal motor nucleus of the vagus (DMV; Fig. 5a8 ), and the ventrolateral periaqueductal gray (vlPAG; Supplementary Fig. 5a ). In the LPBN, axons of PVH TrkB neurons mainly terminate at the central compartment, which is next to the CGRP (calcitonin generelated peptide)-marked external compartment 50 (Fig. 5b) .
The projection to the ME is expected, as TrkB is expressed in a fraction of PVH neurons expressing GHRH ( Supplementary Fig. 1d ) and oxytocin ( Fig. 1b) , which project to the ME and the posterior pituitary via the ME, respectively, to release hormones. To validate other putative projection fields, we injected retrograde tracers, Alexa Fluor 488-conjugated cholera toxin subunit B (CTB488) or green retrobead (GRB), into each of these fields in tamoxifen-treated 
Projection-specific gene deletion
In order to determine at which projection PVH TrkB is necessary for the regulation of appetite, we designed a two-virus system for projection-specific gene deletion. In this strategy, one viral vector is a retrograde virus [canine adenovirus 2 (CAV2) 51 or retrograde AAV (AAVretro) 52 ] expressing yeast flippase (FLP), whereas the other viral vector is AAV2-Ef1a-fDIO-mCherry-P2A-Cre, in which expression of mCherry-P2A-Cre is dependent on FLP-mediated recombination at two sets of Frt sequences (Fig. 6a ). If we stereotaxically inject FLP-expressing retrograde virus into the LPBN and AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH, the retrograde virus would be taken up at axonal terminals and retrogradely transported to the cell bodies of neurons that project to the LPBN. In the PVH, FLP expressed in neurons that project to the LPBN would mediate recombination between the two sets of Frt sites in AAV2-Ef1a-fDIO-mCherry-P2A-Cre and invert the orientation of the mCherry-P2A-Cre sequence, leading to the expression of mCherry and Cre ( Fig. 6a ). If the two viral vectors are injected into Ntrk2 lox/lox mice, expressed Cre would delete the Ntrk2 gene in PVH neurons that project to the LPBN.
We conducted a proof-of-principle experiment to test this projection-specific gene deletion approach in the well-defined substantia nigra ® striatum projection. We injected CAV2-FLPo, which expresses optimized FLP, into the striatum and AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the substantia nigra of Bdnf klox/+ mice ( Fig. 6b1 ). Bdnf klox/+ mice contains a uniquely floxed Bdnf allele that starts to express b-galactosidase in BDNF-expressing cells when Cre recombines the allele 53 . We detected many mCherry-expressing neurons in the substantia nigra ( Fig. 6b2 ), indicating that CAV2-FLPo was retrogradely transported to the substantia nigra from the striatum and induced mCherry expression from AAV2-Ef1a-fDIO-mCherry-P2A-Cre. Because mCherry and Cre are in the same cistron, mCherry-positive neurons should also express Cre, which would mediate recombination of the Bdnf klox allele. Indeed, we found that some mCherry-positive neurons expressed b-galactosidase in the substantia nigra ( Fig. 6b2-4) , where ~50% dopaminergic neurons express BDNF 54 . As expected, we detected expression of neither mCherry nor b-galactosidase in the substantia nigra when CAV2-FLPo was not injected into the striatum ( Supplementary Fig. 6a-d ). This experiment shows that our two-virus system works for projectionspecific gene deletion.
Deletion of the Ntrk2 gene in PVH neurons projecting to the VMH and LPBN leads to hyperphagia and obesity
We targeted the Ntrk2 gene in PVH neurons that project to the NTS, VMH and LPBN, the three main projection fields of PVH TrkB neurons. Retrograde virus CAV2-FLPe-GFP (expressing a fusion protein of GFP and the improved FLP), CAV2-FLPo, or AAV2retro-hSyn-FLPo-T2A-GFP were used to express FLP in cell bodies of afferent neurons. We conducted this study only in female mice. Because Ntrk2 deletion in the PVH produced more severe obesity in females than males ( Fig. 3b and Supplementary Fig. 3h ), we used female mice to more sensitively uncover the role of different PVH TrkB projections in the control of appetite.
To delete the Ntrk2 gene in PVH neurons projecting to the NTS (PVH TrkB®NTS neurons), we injected CAV2-FLPe-GFP into the NTS and either AAV2-Ef1a-fDIO-mCherry (control) or AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH in Ntrk2 lox/lox mice ( Supplementary Fig. 6e ).
Because the NTS is a long structure, we infused a mixture of CAV2-FLPe-GFP and GRBs into two sites, the rostral part ( Supplementary Fig. 6f1-3 ) and the caudal part ( Supplementary Fig. 6f4-6 ) of the central NTS. Co-injected GRBs allows us to determine if an injection hits the NTS ( Supplementary Fig. 6f ). In hit mice, we detected mCherry expression in the PVH ( Supplementary   Fig. 6g ), indicating expression of Cre in AAV2-Ef1a-fDIO-mCherry-P2A-Cre injected mice, which would delete the Ntrk2 gene in positive neurons. We found comparable body weight ( Supplementary Fig. 6h ), body composition ( Supplementary Fig. 6i ) and food intake ( Supplementary Fig. 6j ) between mutant mice and control mice. These results suggest that TrkB in PVH TrkB®NTS neurons is not essential for the control of food intake and body weight.
We next targeted the Ntrk2 gene in PVH neurons projecting to the VMH (PVH TrkB®VMH neurons) by injecting a mixture of CAV2-FLPo and AAV-GFP into the VMH and either AAV2-Ef1a-fDIO-mCherry or AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH in Ntrk2 lox/lox mice (Fig. 6c1 ).
Co-injected AAV-GFP marks injection sites (Fig. 6c2 ). In our initial trial, we noticed lesions at CAV2-FLPo injection sites, likely due to an immune response to CAV2. Therefore, we treated Ntrk2 lox/lox mice with the immunosuppressant cyclophosphamide (50 mg/kg, i.p.) once every 2 d from day -3 to day 13 as previously described 55 . Ten weeks after CAV2 injection, we did not detect any lesions in the VMH (Fig. 6c2 ), indicating that cyclophosphamide successfully blocked the immune response to CAV2. In mice with successful viral injection as evidenced by bilateral mCherry expression in the PVH (Fig. 6c3 and 6c4 ), the Cre group had significantly higher body weight (Fig. 6d) , fat mass and lean mass (Fig. 6c ), body length (Fig. 6f) , and food intake (Fig. 6g) .
These results show that deleting Ntrk2 in PVH TrkB®VMH neurons leads to hyperphagia and obesity, indicating a crucial role for TrkB in PVH TrkB®VMH neurons in appetite suppression.
Finally, we deleted the Ntrk2 gene in PVH neurons projecting to the LPBN (PVH TrkB®LPBN neurons) by injecting AAV2retro-hSyn-FLPo-T2A-GFP into the LPBN and either AAV2-Ef1a-fDIO-mCherry or AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH in Ntrk2 lox/lox mice (Fig. 7a1 ). We employed AAV2retro-hSyn-FLPo-T2A-GFP rather than CAV2-FLPo for the PVH ® LPBN projection, because we found that AAVretro is more efficient in retrograde infection than CAV2 at this projection. AAV2retro-hSyn-FLPo-T2A-GFP expresses GFP at injection sites (Fig. 7a2 ), allowing us to assess the accuracy of each injection. In mice with successful viral injection as evidenced by GFP expression in the LPBN (Fig. 7a2 ) and mCherry expression in the PVH (Fig.   7a3 and 7a4 ), the Cre group had significantly higher body weight (Fig. 7b) , fat mass and lean mass ( Fig. 7c ), body length (Fig. 7d ), and food intake (Fig. 7e) . These results show that deleting Ntrk2 in PVH TrkB®LPBN neurons also leads to hyperphagia and obesity, indicating a crucial role for TrkB in PVH TrkB®LPBN neurons in the control of food intake.
PVH TrkB neurons projecting to the LPBN are distinct from those projecting to the VMH and respond to nutritional state
Because the TrkB receptor at both PVH TrkB projections to the VMH and the LPBN is crucial for the control of appetite, we next investigated the possibility that the same subset of PVH TrkB neurons send collaterals to the VMH and the LPBN. We stereotaxically injected retrograde tracers CTB488 and Alexa Fluor 594-conjugated CTB (CTB594) into the VMH and LPBN, respectively ( Fig. 7f1-3 ). We found that CTB594 mainly labeled cell bodies in the rostral and medial parts of the PVH, whereas CTB488 largely in the medial and caudal parts of the PVH (Fig. 7f4-7) . No neurons were detected to contain both CTB488 and CTB594 (Fig. 7f4-7) . These results indicate that two distinct subtypes of PVH TrkB neurons project to the VMH and the LPBN.
The observation that abolishment of Ntrk2 expression in PVH TrkB®VMH and PVH TrkB®LPBN neurons leads to hyperphagic obesity suggests that these two subtypes of neurons respond to changes in nutritional state. We tested this hypothesis in PVH TrkB®LPBN neurons. We injected CTB488 into the LPBN of tamoxifen-treated Ntrk2 CreER/+ ;Rosa26 Ai9/+ mice. After the mice were extensively handled, they were fasted overnight and a half of them were refed for 2 h. We found that more CTB488-labeled PVH TrkB neurons expressed Fos in refed mice than in fasted mice (Fig.   7g , h), indicating that refeeding activates PVH TrkB®LPBN neurons. These results together with the findings from Ntrk2 deletion and manipulation of neuronal activity, shows that feeding activates PVH TrkB®VMH and PVH TrkB®LPBN neurons to suppress appetite.
DISCUSSION
This study has identified the PVH as a main site where TrkB signaling works to suppress food intake. Using a projection-specific gene deletion strategy we designed, we have further narrowed down the action site of TrkB signaling to two distinct subtypes of PVH neurons that project to the LPBN and the VMH, respectively. Given that BDNF-TrkB signaling is known to potentiate synaptic transmission in the hippocampus 18, 19 , these results suggest that some PVH TrkB neurons are activated to suppress appetite. Indeed, we have found in mice that refeeding activates PVH TrkB®LPBN neurons and that chemogenetic activation of PVH TrkB neurons inhibits food intake during the dark cycle or after overnight food deprivation. Thus, our study indicates that signals reflecting repletion activate PVH TrkB neurons to promote satiety through their outputs to the LPBN and the VMH.
We found that deletion of the Ntrk2 gene with the Sim1-Cre transgene led to hyperphagia and reduced energy expenditure in mice. This observation is in agreement with the previous finding that BDNF expressed in the PVH suppresses food intake and promotes adaptive thermogenesis 22 . Collectively, these results demonstrate that BDNF-TrkB signaling plays a critical role in the control of both energy intake and energy expenditure. When we selectively deleted the Ntrk2 gene in the PVH using stereotaxic injection of Cre-expressing AAV, mutant mice displayed marked hyperphagia but normal energy expenditure. It is likely that TrkB signaling in other brain areas that express Sim1-Cre is involved in the regulation of energy expenditure. One of these brain areas could be the DMH, in which Ntrk2 deletion significantly reduces energy expenditure 28 .
Injection of BDNF protein into the PVH was reported to increase energy expenditure 37 . This could be a result of activation of the TrkB receptor at axonal terminals of neurons that project to the PVH or a non-specific effect of recombinant BDNF.
A genetically defined group of neurons in a specific brain structure usually have multiple projection fields, and the powerful optogenetic approach is commonly employed to uncover the role of the neurons at each projection in animal behaviors. For example, Garfield et al. expressed channelrhodopsin-2 (ChR2) in PVH MC4R neurons and found that light activation of ChR2 at PVH MC4R axonal terminals in the LPBN inhibited food intake, indicating that the PVH MC4R ® LPBN neurocircuit promotes satiety 27 . However, this approach is not suitable for uncovering gene function and is not ideal for examination of the long-term effect of altering neuronal activity. The projection-specific gene deletion described here makes it possible to determine the function of a gene in a specific neurocircuit. If deletion of a gene also alters the function of the targeted neurocircuit, the same experiment will also reveal both short-term and long-term impacts of altering the activity of the circuit on behaviors and physiology.
Using the projection-specific gene deletion approach, we have identified two subtypes of PVH TrkB neurons (PVH TrkB®LPBN neurons and PVH TrkB®VMH neurons) in which TrkB signaling is necessary to suppress appetite. Deletion of the Ntrk2 gene in one of these two subtypes of neurons led to hyperphagia and obesity. Furthermore, we have found that refeeding activates PVH TrkB®LPBN neurons and that chemogenetic stimulation/inhibition of PVH TrkB neurons greatly decreases/increases food intake, respectively. These results suggest that abolishment of TrkB signaling impairs the function of these two subtypes of neurons, which leads to deficits in transmitting satiation signals to their target neurons in the LPBN and VMH. These results also indicate that the PVH TrkB ®LPBN and PVH TrkB ®VMH neurocircuits are satiating and that BDNF is a key modulator of the two anorexigenic neurocircuits. As BDNF potently potentiates synaptic transmission 19 , it is likely that TrkB signaling enhances synaptic transmission in the two subtypes The vast majority of PVH neurons are glutamatergic neurons 56 . These neurons have been shown to provide excitatory drive to the AgRP neurons in the arcuate nucleus 57 , the cLPBN 27 , and the pre-locus coeruleus (pLC) 28 to regulate satiety. This study identifies one more neurocircuit out of the PVH, i.e. PVH TrkB ®VMH, to regulate satiety.
Although ablation of the oxytocin receptor-expressing neurons in the hindbrain leads to overeating 42 , ablation of PVH oxytocin neurons in adult mice has no effect on body weight, food intake, or energy expenditure 47 neurons, which project to the same target field, the cLPBN. It would be intriguing to know whether these two subtypes of neurons innervate the same neurons in the cLPBN and receive inputs from the same afferent neurons. These future studies will provide insights into the organization and function of the neural network that regulates appetite. 
METHODS
Animals.
Floxed Ntrk2 (Ntrk2 lox ; also known as TrkB lox ) 41 , floxed Ntrk2-LacZ (Ntrk2 fBZ ; also known as fBZ) 40 , and floxed Bdnf (Bdnf klox ) 53 mouse strains were previously described. Ntrk2 lox mice were backcrossed to C57BL/6J mice for at least 15 generations before they were used in this study. To construct pCAV2-FLPe-GFP, we inserted the Flpe-GFP sequence into the CAV shuttle plasmid 58 to generate pShuttle-FLPe-GFP. The FLPe-GFP sequence was isolated from pCAG-Flpe-GFP (a gift from Connie Cepko, Addgene plasmid #13788). The AscI-PacI fragment of the shuttle construct was purified and used to generate pCAV2-FLPe-GFP through homologous recombination in E. coli as described 59 . To generate pCAV2-FLPo, we began with pCAV-FLEx loxP -Flp 60 . pCAV-FLEx loxP -Flp contains the CAV-2 genome deleted in the E1 and E3 regions, and a cassette containing a CMV promoter, two loxP sites, an inverted FLPo open reading frame, and an SV40 polyA signal. pCAV-FLEx loxP -Flp was incubated with recombinant Cre recombinase (New England Biolabs) and then transformed into DHa bacteria. A clone containing the FLPo cassette in the 5¢ ® 3¢ orientation was identified by restriction digestion analyses and denoted pCAV2-FLPo. Viral vectors CAV2-FLPe-GFP and CAV2-FLPo were generated, amplified, and purified as previously described 58 .
Stereotaxic injection of virus and CTB.
The stereotaxic surgeries were performed as previously described 22 . Mice were deeply anesthetized with isoflurane and were placed onto a stereotaxic apparatus (David Kopf, Model 940). A small incision was made to expose the skull, and a small hole was drilled on skull above the injection site. A Nanofil 33-gauge needle (World Precision Instruments, #NF33BV-2) was inserted into the brain and the virus was injected at a rate of 25 nl/min using Microsyringe Pump (World Precision Instruments, Micro4). After infusion, the needle was stayed in the same position for 5 min. Chemogenetic manipulation of food intake. Mice injected with AAV2-hSyn-DIO-mCherry, AAV2-hSyn-DIO-hM3D(Gq)-mCherry or AAV2-hSyn-DIO-hM4D(Gi)-mCherry were singly housed for at least 2 weeks with daily handling prior to experiment. For food intake measurement during light cycle, mice were transferred to a new cage without food at 7:30 am and injected intraperitoneally with vehicle or CNO (Sigma-Aldrich #C08325) at 8:30 am. Pre-weighed food was then added to each cage at 9:00 am and food intake was measured hourly for 3 h. For food intake measurement during dark cycle, mice were transferred to a new cage without food at 3 pm and injected with vehicle or CNO at 5:30 pm. Pre-weighed food was then added to each cage at 6:00 pm and food intake was measured hourly from 7:00 pm to 9:00 pm. For food intake measurement after overnight fasting, mice were transferred to a new cage with alpha-dri bedding without food at 6:00 pm for overnight fasting. On the following day, mice were injected with vehicle or CNO at 9:30 am and pre-weighed food was added to each cage at 10:00 am and food intake was measured hourly for 3 h. The CNO dosage was 1 mg/kg body weight for mice injected with AAV2-hSyn-DIO-hM3D(Gq)-mCherry and 3 mg/kg body weight for mice injected with AAV2-hSyn-DIO-hM4D(Gi)-mCherry.
In situ hybridization. Freshly dissected mouse brains were quickly frozen in a 2-methylbutane (Fisher Scientific #O3551-4) dry ice bath. Subsequently, 20-µm thick cryostat sections were collected on Superfrost Plus slides (Fisherbrand #12-550-15) and used for in situ hybridization.
Radioactive in situ hybridization of brain sections was performed using 35 S-labeled riboprobes as previously described 11 . To generate antisense riboprobes, the mouse cDNA sequence for Ntrk2 GFP fluorescence indicates precise injection of AAV2-CMV-GFP into the PVH bilaterally (a1). In situ hybridization shows abolishment of Ntrk2 expression in the PVH of Ntrk2 lox/lox mice injected with AAV2-CMV-Cre-GFP, but not AAV2-CMV-GFP (a2). Arrows denote the PVH. (b) Body weight of Ntrk2 lox/lox mice injected with either AAV2-CMV-GFP or AAV2-CMV-Cre-GFP into the PVH bilaterally. Mice injected with AAV2-CMV-Cre-GFP were divided into two groups: AAV2-CMV-Cre-GFP (missed) mice in which there was little viral transduction in the PVH and AAV2-CMV-Cre-GFP (hit) mice in which there was significant viral transduction in the PVH. n = 4 mice for AAV2-CMV-GFP, 5 mice for AAV2-CMV-Cre-GFP (missed), and 6 mice for AAV2-CMV-Cre-GFP (hit). Two-way ANOVA with post hoc Bonferroni multiple comparisons; F(2, 120) = 37.13, P < 0.0001 for viral injection; **P < 0.01 and ***P < 0.001 for comparisons between AAV2-CMV-Cre-GFP (hit) and AAV2-CMV-GFP or AAV2-CMV-Cre-GFP (missed). (c) Body composition of Ntrk2 lox/lox mice 9 weeks after AAV injection. Student's t test; ***P < 0.001. A mixture of CAV2-FLPo + AAV2-CMV-GFP (350 nl, 5:1 ratio) and either AAV2-Ef1a-fDIO-mCherry (control) or AAV2-Ef1a-fDIO-mCherry-P2A-Cre (150 nl) were bilaterally injected into the VMH and PVH of Ntrk2 lox/lox mice, respectively (c1). Co-injected AAV2-CMV-GFP was used to mark CAV2 injection sites (c2). Neurons that are transduced by both CAV2-FLPo and one of the two FLP-dependent AAV vectors would express mCherry (c3 and c4). (d-g) Body weight (d), fat mass and lean mass (e), body length (f), and food intake (g) of female Ntrk2 lox/lox mice injected with CAV2-FLPo into the VMH and either AAV2-Ef1a-fDIO-mCherry or AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH. Body weight data were analyzed using two-way ANOVA Figure 7 . PVH neurons projecting to the LPBN are activated by refeeding and their TrkB expression is crucial for appetite suppression. (a) Deletion of the Ntrk2 gene in PVH neurons projecting to the LPBN. AAV2retro-hSyn-FLPo-T2A-GFP (200 nl) and either AAV2-Ef1a-fDIO-mCherry (control) or AAV2-Ef1a-fDIO-mCherry-P2A-Cre (150 nl) were bilaterally injected into the LPBN and PVH of Ntrk2 lox/lox mice, respectively (a1). GFP marks injection sites of AAV2retro-hSyn-FLPo-T2A-GFP (a2). Neurons that are transduced by both AAV2retro-hSyn-FLPo-T2A-GFP and one of the two FLP-dependent AAV vectors would express mCherry (a3 and a4). (b-e) Body weight (b), fat mass and lean mass (c), body length (d), and food intake (e) of female Ntrk2 lox/lox mice injected with AAV2retro-hSyn-FLPo-T2A-GFP into the LPBN and either AAV2-Ef1a-fDIO-mCherry or AAV2-Ef1a-fDIO-mCherry-P2A-Cre into the PVH. Body weight data were analyzed using two-way ANOVA with Bonferroni post hoc tests; F (1, 126) 
